Management and Prevention of Cytomegalovirus Infection After Renal Transplantation
- 1 September 1992
- journal article
- review article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 67 (9), 879-890
- https://doi.org/10.1016/s0025-6196(12)60828-3
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow TransplantsNew England Journal of Medicine, 1991
- GanciclovirDrugs, 1990
- A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal AllograftsNew England Journal of Medicine, 1989
- Progressive Disease Due to Ganciclovir-Resistant Cytomegalovirus in Immunocompromised PatientsNew England Journal of Medicine, 1989
- Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant RecipientsNew England Journal of Medicine, 1987
- Acquisition of Donor Strains of Cytomegalovirus by Renal-Transplant RecipientsNew England Journal of Medicine, 1986
- MULTICENTER SEROEPIDEMIOLOGIC STUDY OF THE IMPACT OF CYTOMEGALOVIRUS INFECTION ON RENAL TRANSPLANTATIONTransplantation, 1985
- Association of Herpesvirus Infections with T-Lymphocyte-Subset Alterations, Glomerulopathy, and Opportunistic Infections after Renal TransplantationNew England Journal of Medicine, 1983
- Glomerulopathy Associated with Cytomegalovirus Viremia in Renal AllograftsNew England Journal of Medicine, 1981
- Cytomegalovirus Viremia and Bacteremia in Renal-Allograft RecipientsNew England Journal of Medicine, 1978